Cellectis (NASDAQ: CLLS) reported Q2 EPS of (EUR0.23), versus (EUR0.43) reported last year. Revenue for the quarter came in at EUR18.14 million, versus EUR8 million reported last year.

For earnings history and earnings-related data on Cellectis (CLLS) click here.